c
2
12
18
28
12
12
1a
14
e
12
16
a
a
2
2
a
20
32
1a
2a
19
Faculty
61 16
19
1
49
2
2
1a
32
34
1b
1d
18
33
46
1d
2 29
1d
25
Gregory Corder, Ph.D.
88
46
Assistant Professor of Psychiatry
7
61
Department: Psychiatry
4
1
23
1f
Graduate Group Affiliations
8
b
-
64
- Neuroscience 6a
- Pharmacology e
1d
46
Contact information
40
4
3
3
1d
40
125 S. 31st Street
49 Translational Research Labs - Rm. 2201
Philadelphia, PA 19104
26
49 Translational Research Labs - Rm. 2201
Philadelphia, PA 19104
2c
Office: 8133820018
30
83
30
Email:
gcorder@upenn.edu
12
gcorder@upenn.edu
18
Publications
23 a
3
2
4
b
1f
23 a
13
Education:
21 9 B.S. 27 (Cell and Molecular Biology) c
3b Tulane University, New Orleans, LA, 2007.
21 a Ph.D. 20 (Dept. of Physiology) c
3e University of Kentucky, Lexington, KY, 2013.
c
3
27
5
3
3
92
Permanent link21 9 B.S. 27 (Cell and Molecular Biology) c
3b Tulane University, New Orleans, LA, 2007.
21 a Ph.D. 20 (Dept. of Physiology) c
3e University of Kentucky, Lexington, KY, 2013.
c
2 29
21
1e
1d
24
76
8
1f7 My lab combines miniscope imaging and machine learning to decode the neural dynamics of pain perception, identifying how nociceptive circuits undergo maladaptive changes leading to chronic pain. Pain is more than a sensory experience—it is an emotionally charged state that commands attention, alters cognition, and disrupts behavior. Our work aims to map the circuits and molecular mechanisms underlying this transition, providing a framework for developing new, translational pain therapies.
8
1ff A major focus of my research is opioid pharmacology and addiction-related plasticity. In response to the Opioid Epidemic and the need for safer pain management strategies, my lab is investigating non-opioid analgesic therapies, circuit-level mechanisms of opioid action, and gene therapies for chronic pain. We have pioneered activity-dependent genetic tools for capturing pain-active neurons, developed next-generation circuit-based therapies, and identified new pathways for non-addictive pain relief.
8
1dc By integrating systems neuroscience, computational modeling, and translational pharmacology, my lab aims to bridge basic discovery with therapeutic innovation, developing more effective, non-addictive treatments for chronic pain and opioid dependence. Beyond research, I am committed to mentoring the next generation of neuroscientists, with a strong record of trainee fellowships and mentoring, interdisciplinary collaboration, and leadership in neuroscience training.
e 29
27
Description of Research Expertise
28b The Corder Lab at Penn seeks to decipher the neural basis of pain perception, investigate how pathological changes in brain networks drive chronic pain and opioid dependence, and develop novel therapeutic strategies. I am a neuroscientist and pain researcher focused on understanding how pain and motivated behaviors emerge from neural circuit activity. My research integrates in vivo calcium imaging, optogenetics, viral tool development, single-nuclei RNA sequencing, neuroanatomical tracing, and deep-learning behavior modeling to uncover how brain circuits encode pain, pleasure, and affective states in preclinical rodent models.8
1f7 My lab combines miniscope imaging and machine learning to decode the neural dynamics of pain perception, identifying how nociceptive circuits undergo maladaptive changes leading to chronic pain. Pain is more than a sensory experience—it is an emotionally charged state that commands attention, alters cognition, and disrupts behavior. Our work aims to map the circuits and molecular mechanisms underlying this transition, providing a framework for developing new, translational pain therapies.
8
1ff A major focus of my research is opioid pharmacology and addiction-related plasticity. In response to the Opioid Epidemic and the need for safer pain management strategies, my lab is investigating non-opioid analgesic therapies, circuit-level mechanisms of opioid action, and gene therapies for chronic pain. We have pioneered activity-dependent genetic tools for capturing pain-active neurons, developed next-generation circuit-based therapies, and identified new pathways for non-addictive pain relief.
8
1dc By integrating systems neuroscience, computational modeling, and translational pharmacology, my lab aims to bridge basic discovery with therapeutic innovation, developing more effective, non-addictive treatments for chronic pain and opioid dependence. Beyond research, I am committed to mentoring the next generation of neuroscientists, with a strong record of trainee fellowships and mentoring, interdisciplinary collaboration, and leadership in neuroscience training.
e 29
23
1b3 Corder, G*, Tawfik, VL*, Wang, D*, Sypek, ES*, Low, SA, Dickinson, JR, Sotoudeh, C, Clark, JD, Barres, B, Bohlen, C, Scherrer, G.: Loss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia. Nature Medicine 23(2): 164-173, Feb 2017 Notes: doi: 10.1038/nm.4262. * denotes equal contributions.
2c
7
1d
1f
Selected Publications
156 Corder, G*, Castro, D*, Bruchas, M, Scherrer, G.: Exogenous and endogenous opioids in pain. Annual Review of Neuroscience 41: 453-473, July 2018 Notes: doi: 10.1146/annurev-neuro-080317-061522. https://www.annualreviews.org/neuro/planned. * denotes equal contributions.1b3 Corder, G*, Tawfik, VL*, Wang, D*, Sypek, ES*, Low, SA, Dickinson, JR, Sotoudeh, C, Clark, JD, Barres, B, Bohlen, C, Scherrer, G.: Loss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia. Nature Medicine 23(2): 164-173, Feb 2017 Notes: doi: 10.1038/nm.4262. * denotes equal contributions.
2c
4d
22
22
7
10
a
a
2
2
19
18
10
22
10
11
c
5b © The Trustees of the University of Pennsylvania | Site best viewed a in a supported browser. | Site Design: 57 PMACS Web Team. 3 22
10